News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,241 Results
Type
Article (87990)
Company Profile (825)
Press Release (781407)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233272)
Career Advice (4147)
Deals (39883)
Drug Delivery (151)
Drug Development (91423)
Employer Resources (205)
FDA (18395)
Job Trends (17428)
News (397940)
Policy (39970)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (56981)
ALS (181)
Alzheimer's disease (1791)
Antibody-drug conjugate (ADC) (346)
Approvals (18575)
Artificial intelligence (626)
Autoimmune disease (162)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (202)
Biotechnology (490)
Bladder cancer (163)
Brain cancer (65)
Breast cancer (662)
Cancer (5038)
Cardiovascular disease (444)
Career advice (3570)
Career pathing (41)
CAR-T (303)
CDC (59)
Celiac Disease (2)
Cell therapy (826)
Cervical cancer (37)
Clinical research (77029)
Collaboration (1822)
Company closure (5)
Compensation (1155)
Complete response letters (73)
COVID-19 (2992)
CRISPR (99)
C-suite (865)
Cystic fibrosis (154)
Data (6272)
Decentralized trials (2)
Denatured (72)
Depression (151)
Diabetes (532)
Diagnostics (7230)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (302)
Drug pricing (224)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100147)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135076)
Executive appointments (1033)
FDA (21577)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1556)
Gene editing (215)
Generative AI (64)
Gene therapy (671)
GLP-1 (1127)
Government (5441)
Grass and pollen (8)
Guidances (385)
Healthcare (20946)
HIV (60)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (292)
Immuno-oncology (59)
Indications (98)
Infectious disease (3279)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (247)
Interviews (816)
IPO (17955)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (69)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (16)
Lung cancer (679)
Lymphoma (379)
Machine learning (45)
Management (66)
Manufacturing (854)
MASH (173)
Medical device (15028)
Medtech (15080)
Mergers & acquisitions (22986)
Metabolic disorders (1395)
Multiple sclerosis (162)
NASH (23)
Neurodegenerative disease (355)
Neuropsychiatric disorders (98)
Neuroscience (3112)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (674)
Opinion (336)
Ovarian cancer (167)
Pain (210)
Pancreatic cancer (231)
Parkinson's disease (300)
Partnered (39)
Patents (510)
Patient recruitment (479)
Peanut (60)
People (66915)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23798)
Phase II (33423)
Phase III (25193)
Pipeline (5064)
Policy (336)
Postmarket research (3554)
Preclinical (10693)
Press Release (72)
Prostate cancer (246)
Psychedelics (55)
Radiopharmaceuticals (301)
Rare diseases (905)
Real estate (7440)
Recruiting (80)
Regulatory (29028)
Reports (67)
Research institute (2725)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (257)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (100)
The Weekly (122)
Vaccines (1147)
Venture capital (96)
Weight loss (462)
Women's health (88)
Worklife (21)
Date
Today (110)
Last 7 days (543)
Last 30 days (2515)
Last 365 days (32843)
2026 (2552)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (89)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51563)
Australia (9058)
California (11544)
Canada (3314)
China (1167)
Colorado (488)
Connecticut (500)
Delaware (346)
Europe (118458)
Florida (1689)
Georgia (371)
Hawaii (4)
Idaho (68)
Illinois (964)
India (67)
Indiana (543)
Iowa (24)
Japan (429)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1456)
Massachusetts (8493)
Michigan (358)
Minnesota (665)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3106)
New Mexico (33)
New York (3047)
North Carolina (1611)
North Dakota (10)
Northern California (5519)
Ohio (354)
Oklahoma (22)
Oregon (55)
Pennsylvania (2311)
Puerto Rico (22)
Rhode Island (50)
South America (1661)
South Carolina (65)
South Dakota (1)
Southern California (4458)
Tennessee (177)
Texas (1821)
United States (41640)
Utah (346)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (972)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
There are 870,241 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FRUZAQLA(TM) (fruquintinib capsules) now reimbursed in Ontario to treat metastatic colorectal cancer (mCRC)
February 2, 2026
·
4 min read
Press Releases
Crystalys Therapeutics Expands Phase 3 RUBY Study With First Patients Dosed at European Sites
February 2, 2026
·
2 min read
Press Releases
Teva Canada Announces Strategic Partnership with Novartis Canada to Relaunch Mayzent® for Multiple Sclerosis Patients in Canada
February 2, 2026
·
2 min read
Rare diseases
GSK Hands RNA Editor Back to Wave After Underwhelming Early AATD Data
While GSK did not provide a specific reason for returning Wave Life Sciences’ WVE-006, the decision comes after the asset in September 2025 came below analyst expectations in a Phase Ib/IIa AATD study.
February 2, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Hydreight Technologies Issues Fiscal 2026 Revenue Guidance of ≈ $150 Million and Provides Q1 2026 Outlook
February 2, 2026
·
11 min read
Press Releases
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
February 2, 2026
·
9 min read
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Press Releases
ORYZON Strengthens Patent Portfolio for Vafidemstat With New Decision to Grant in Japan
February 2, 2026
·
7 min read
Press Releases
Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial
February 2, 2026
·
6 min read
Press Releases
Abinopharm, Inc. Releases AbinoNutra® NMN White Paper Following FDA Reinstatement and Human Clinical Trial Evidence
February 2, 2026
·
3 min read
1 of 87,025
Next
